Thirty-percent of Keytruda’s U.S. sales came from its lung-cancer indication.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma’s access to docs declines
Approximately 10% to 15% of lung cancer patients have never smoked and have developed the disease due to genetic alterations.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to: